CARDIOMYOPATHY, HYPERTROPHIC
Clinical trials for CARDIOMYOPATHY, HYPERTROPHIC explained in plain language.
Never miss a new study
Get alerted when new CARDIOMYOPATHY, HYPERTROPHIC trials appear
Sign up with your email to follow new studies for CARDIOMYOPATHY, HYPERTROPHIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart rhythm battle: zapping vs. pills for Life-Threatening condition
Disease control OngoingThis study compares two approaches for controlling dangerous rapid heart rhythms (ventricular tachycardia) in people with weakened heart muscles. Researchers are testing whether a procedure called catheter ablation (using heat or cold to destroy small areas of heart tissue causin…
Matched conditions: CARDIOMYOPATHY, HYPERTROPHIC
Phase: NA • Sponsor: Western Sydney Local Health District • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for teens with rare, debilitating heart condition
Disease control OngoingThis study is testing whether the medication mavacamten can help control symptoms and reduce strain on the heart in teenagers (ages 12-17) who have a genetic condition that causes the heart muscle to thicken and obstruct blood flow. It is a Phase 3 trial involving 44 participants…
Matched conditions: CARDIOMYOPATHY, HYPERTROPHIC
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Heart drug put to the test: can it remodel a thickened heart?
Disease control OngoingThis study is testing if the drug mavacamten can improve the physical structure of the heart in adults with a condition called obstructive hypertrophic cardiomyopathy (oHCM), where the heart muscle is abnormally thick. Researchers will use special heart MRI scans to measure chang…
Matched conditions: CARDIOMYOPATHY, HYPERTROPHIC
Phase: PHASE4 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC